RxDoctor Payments Data

George Hanna, MD

Neurological Surgery · West Hollywood, CANPI 1609212281

Payments from drug & device makers

What this record shows

This record is dominated by grants: $20,000 of the $27,029 with a category attached, or 74.0%. Medtronic accounts for 78.9% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $17,125, more than ten times the $655 reported in 2020.

$27,029in general payments, 2019–2025

Across 64 payments — averaging $422.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$21K
  • Boston Scientific$2K
  • Icotec Medical Inc.$2K
  • Alphatec Spine, Inc$544
  • Integra Lifesciences Corporation$438
  • Sanara Medtech Inc.$353
  • plus $718 from 11 others
$950in research payments, 2019–2025

Across 1 payment — averaging $950.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Prosidyan, Inc$950

What the payments were for

  • Grants$20,00074%
  • Travel & lodging$2,4329%
  • Food & beverage$4,33116%
  • Education$2671%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,029 in reported general payments places this provider in the 75th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California →

Medicare billing

Part B allowed, 2024
$165,554
Medicare patients
311
Services billed
837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin97$978
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$190
Methocarbamol22$179
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$177
Clindamycin Hcl11$157
Methylprednisolone36$157

Paid to pharmacies, not to this prescriber.

Other neurological surgery in West Hollywood

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →